The Good Bug

Mumbai, India Founded: 2021 • Age: 5 yrs Minicorn
Synbiotic supplements and fermented products for gut health are provided.

About The Good Bug

The Good Bug is a Healthcare company based in Mumbai (India) founded in 2021 by Keshav Biyani and Prabhu Karthikeyan Veluswamy. Synbiotic supplements and fermented products for gut health are provided. The Good Bug has raised $20.02 million across 4 funding rounds from investors including Think9, Sharrp Ventures and The Good Gut Private Family Trust. The company has 88 employees. The Good Bug was last valued at $80.73 million in April 2025. Its website thegoodbug.com draws about 373 thousand monthly visits. Its Indian entity Seven Turns Private Limited reported revenue of ₹89.75 Cr. The Good Bug offers products and services including Gut Balance, Bye Bye Bloat, Metabolically Lean, and Glycemic Control. Its focus areas include Life Sciences, Nutraceuticals Tech, Functional Foods and Beverages and Probiotics.

Company details

Provider of synbiotic supplements and fermented products for gut health. It offers a range of products addressing various health concerns, including weight management, bloating, constipation, and immune support. These products utilize clinically validated probiotic strains formulated for optimal gut survival. The company also provides educational resources on gut health and offers expert consultations. Product lines include daily probiotics, prebiotic fibers, super bundles, detox shots, and fermented foods like kombucha and kefir.

  • Headquarters Mumbai, India
  • Employees 88
  • Founders Keshav Biyani, Prabhu Karthikeyan Veluswamy
  • Stage Minicorn
  • Sectors
    Healthcare
  • Website category Finance
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website thegoodbug.com
  • Social LinkedIn Facebook Instagram
  • Legal Name Seven Turns Private Limited
  • Date of Incorporation 23 Oct, 2021
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹89.75 Cr

    FY 2025 · +104% YoY

  • Net Loss
    -₹42.96 Cr

    FY 2025 · -48% margin

  • EBITDA
    -₹42.17 Cr

    FY 2025 · -47% margin

  • Total Equity Funding
    $20.02M (USD)

    in 4 rounds

  • Latest Funding Round
    $11.86M (USD), Series B

    Apr 2025

  • Investors
    Think9

    & 8 more

  • Employee Count
    88

Products & Services of The Good Bug

The Good Bug offers a comprehensive portfolio of products and services, including Gut Balance, Bye Bye Bloat, Metabolically Lean, and Glycemic Control.

Gut Balance
Probiotic Supplement

Improves gut health and relieves digestive issues.

Bye Bye Bloat
Probiotic Supplement

Soothes bloating and gas for better comfort.

Metabolically Lean
Weight Management Supplement

Supports metabolism and weight control naturally.

Glycemic Control
Health Supplement

Helps manage blood sugar levels effectively.

Funding Insights of The Good Bug

The Good Bug has successfully raised a total of $20.02M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $11.86 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $20.02M
  • Total Rounds 4
  • Last Round Series B — $11.86M
  • First Round $1.09M

    (May 2023)

  • Investors Count 9

All 4 funding rounds of The Good Bug with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2025$11.86MSeries B$80.73MSIG Venture Capital, Sai Global India Fund
Oct 2024$3.56MSeries A$33.34MThe Good Gut Private Family Trust, Fireside Ventures
Sep 2023$3.5MSeries A$•••••Fireside Ventures
–
May 2023$1.09MSeries A$•••••Sanvi Business Ventures, Think9
–
Valuation history
DateValuationStage
Apr 2025$80.73M••••••••
Oct 2024$33.34M••••••••
Sep 2023$•••••••••••••
May 2023$•••••••••••••
Premium access

Full valuation and stage history of The Good Bug

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $80.73M (Apr 2025). 9 investors in total: 7 institutional and 2 angel.

Investors in The Good Bug

The Good Bug has secured backing from 9 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Think9, Sharrp Ventures and The Good Gut Private Family Trust.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Early-stage consumer brand companies are invested in by Fireside Ventures.
firesideventures.comBengaluru, India
Investment office backing consumer sector companies in India.
2014sharrpventures.comMumbai, India
Venture capital firm focused on seed and late stage investments
sig-asiavc.comHong Kong, China
Brand co-creation services for digital-native consumer brands are provided.
2021think9co.inMumbai, India

Ameya Chandavarkar

unknown_d415b2603d6046808

Sanjeev Taparia

Angel investor and entrepreneur, focused on tech startups in India.
unknown_dc4763ea84184291a
Premium access

Investor details for The Good Bug

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Seven Turns Private Limited (The Good Bug)

Seven Turns Private Limited is the primary company behind The Good Bug. The board of Seven Turns Private Limited currently have 4 directors; the longest-serving is Prabhu Karthikeyan Veluswamy, appointed in 2021. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Prabhu Karthikeyan Veluswamy
DIN 06655247
Whole-time director23 Oct 20215 yrsSeven Turns Private Limited
Keshav Vijay Biyani
DIN 07869470
Whole-time director03 Mar 20224 yrs 8 moSeven Turns Private Limited
Ankur Khaitan
DIN 10373372
Nominee Director07 May 20242 yrs 6 moSeven Turns Private Limited
Krushani Piyushbhai Desai
DIN 11126181
Director17 Jun 20251 yr 4 moSeven Turns Private Limited

People of The Good Bug

10 people are tracked at The Good Bug (6 in leadership, 4 in team); the tracked headcount is 88.

NameRoleGroup
Co-FounderLeadership
Co-FounderLeadership
Sneha Jaisinghani
Chief Of StaffLeadership
Mahesh Tapadiya
Chief Of StaffLeadership
Eshita Sharma
Head Of ContentLeadership
Chirag Patel
Head Of Procurement & Product SupplyLeadership
Jiten Patel
Senior Lead - Operations & TechnologyTeam
Sanjana Sawant
New Product Development LeadTeam
Vartika Sharma
Senior Creative StrategistTeam
Gargi R.
Senior Brand AssociateTeam
Premium access

Complete people profiles for The Good Bug

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of The Good Bug

Figures of Seven Turns Private Limited, the primary company behind The Good Bug, for FY 2025. Revenue was ₹89.75 Cr (+104% year on year). Net loss was -₹42.96 Cr (-48% margin). EBITDA was -₹42.17 Cr (-47% margin). Revenue has grown at a compounded annual rate of +601% over three years.

  • ₹89.75 CrRevenue · FY 2025 · +104% YoY
  • -₹42.96 CrNet loss · -48% margin
  • -₹42.17 CrEBITDA · -47% margin
  • ₹16 LakhPaid-up capital
  • 106Employees (provident fund records)
  • +601%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Seven Turns Private Limited are on its company page.

Premium access

Detailed financial statements for The Good Bug

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of The Good Bug

4 dated milestones of The Good Bug across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded The Good Bug is founded.
  2. Funding First funding round of $1.1M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series B, of $11.9M.

Web traffic of The Good Bug

The website of The Good Bug (thegoodbug.com) receives about 372.8K visits a month and ranks #134,266 among all websites worldwide, #8,391 in Finance.

  • Monthly visits
    372.8K

    ▲ 13.7% vs previous month

  • Unique visitors
    179.4K

    per month

  • Global rank
    #134,266

    among all websites

  • Category rank
    #8,391

    Finance · Finance

Similar websites

Websites whose visitors overlap most with The Good Bug. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
manmatters.com
100%
1.5M#36,009View details
veerahealth.com
99%
21.3K#1,256,569View details
indianstartupnews.com
98%
353.8K#136,006View details
ourlittlejoys.com
ourlittlejoys.com
98%
#97,210–
daburshop.com
daburshop.com
98%
#95,897–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 16 similar websites and full traffic analytics for The Good Bug

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 16 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as The Good Bug (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Ayurvedic healthcare and nutritional products are provided by Kapiva.
2016Bengaluru, Karnataka, IndiaUSD 77.85 MUSD 55.41 M362
Nutritional supplements for multiple health ailments are developed.
2005Mumbai, Maharashtra, IndiaUSD 1.55 M
Nutritional food and health supplements are provided by OZiva.
2010Mumbai, Maharashtra, IndiaUSD 17.32 MUSD 56.21 M144
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about The Good Bug

Premium access

Complete news archive for The Good Bug

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about The Good Bug

The Good Bug was founded in 2021 and raised its 1st funding round 2 years after it was founded.

The Good Bug is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

The Good Bug is a funded company, having raised a total of $20.02M across 4 funding rounds to date. The company's 1st funding round was a Series A of $1.09M, raised on May 2023.

The Good Bug has 88 employees.

The primary company behind The Good Bug, Seven Turns Private Limited, reported revenue of ₹89.75 Cr for FY 2025, up 104% year on year.

Provider of synbiotic supplements and fermented products for gut health. It offers a range of products addressing various health concerns, including weight management, bloating, constipation, and immune support. These products utilize clinically validated probiotic strains formulated for optimal gut survival. The company also provides educational resources on gut health and offers expert consultations. Product lines include daily probiotics, prebiotic fibers, super bundles, detox shots, and fermented foods like kombucha and kefir.

The Good Bug offers Gut Balance, Bye Bye Bloat, Metabolically Lean, and Glycemic Control.

The Good Bug has 9 investors. Key investors include Think9, Sharrp Ventures, The Good Gut Private Family Trust, Fireside Ventures, and Ameya Chandavarkar.

The valuation of The Good Bug is $80.73M as of Apr 2025.

The Good Bug operates through Seven Turns Private Limited.

The legal entities of The Good Bug currently have 4 directors, including Prabhu Karthikeyan Veluswamy, Keshav Vijay Biyani, Krushani Piyushbhai Desai and others.

The website of The Good Bug receives about 373 thousand visits a month and ranks #134,266 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available